Patents by Inventor Kathrin U. Jansen

Kathrin U. Jansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA encoding human papilloma virus type 18
    Patent number: 6908615
    Abstract: The present invention is directed to DNA molecules encoding purified human papillomavirus type 18 and derivatives thereof.
    Type: Grant
    Filed: March 18, 1996
    Date of Patent: June 21, 2005
    Assignee: Merck & Co., Inc.
    Inventors: Kathryn J. Hofmann, Kathrin U. Jansen, Michael P. Neeper, Joseph G. Joyce, Hugh A. George
  • Staphylococcus aureus exopolysaccharide and process
    Publication number: 20040259838
    Abstract: A high molecular weight polysaccharide intracellular adhesin (SAE) antigen having the general structure of poly-1,6,&bgr;-2-amidoglucopyranoside, which is variable substituted with N-acetyl and O-succinyl substituents is described. Also, a method is given for isolating this antigen from Staphylococcus aureus. The SAE can be used in a vaccine, either alone, conjugated to an immunogenic protein, and/or with an immunogenic adjuvant.
    Type: Application
    Filed: June 9, 2004
    Publication date: December 23, 2004
    Inventors: Joseph G. Joyce, James C. Cook III, Chitrananda Abeygunawardana, Karen M. Grimm, Craig T. Przysiecki, Robert W. Hepler, Charlotte C. Ip, Donald Keith Roper, Qi Wei Xu, Kathrin U. Jansen, Paul M. Keller, Leslie D. Cope
  • Synthetic virus like particles with heterologous epitopes
    Patent number: 6689366
    Abstract: The invention is a series of synthetic virus-like particles comprising a heterologous conformational epitope useful in the characterization of human papillomavirus infection, and useful to vaccinate individual for protection against HPV 6 and HPV 11 infections, and assays employing the synthetic virus-like particles.
    Type: Grant
    Filed: June 4, 2001
    Date of Patent: February 10, 2004
    Assignee: Merck & Co., Inc.
    Inventors: Kathrin U. Jansen, Jessica C. Ling, Steven W. Ludmerer, William L. McClements, Xin-Min Wang
  • DNA encoding human papillomavirus type 6A
    Patent number: 6290965
    Abstract: The present invention is directed to DNA molecules encoding purified human papillomavirus type 6a and compounds derived therefrom.
    Type: Grant
    Filed: March 8, 2000
    Date of Patent: September 18, 2001
    Assignee: Merck & Co., Inc.
    Inventors: Kathrin U. Jansen, Kathryn J. Hofmann
  • Synthetic HPV6/11 hybrid L1 DNA encoding human papillomavirus type 11 L1 protein
    Patent number: 6159729
    Abstract: The present invention is directed to a synthetic DNA molecule encoding purified human papillomavirus type 11 L1 protein and derivatives thereof.
    Type: Grant
    Filed: January 26, 1998
    Date of Patent: December 12, 2000
    Assignee: Merck & Co., Ltd.
    Inventors: Kathryn J. Hofmann, Kathrin U. Jansen, Michael P. Neeper, Joseph G. Joyce, Hugh A. George, E. Dale Lehman
  • Recombinant papillomavirus vaccines
    Patent number: 5888516
    Abstract: Recombinant expression vectors encoding the L1 and L2 proteins of papillomavirus, methods of making and using the recombinant proteins and purified virus-like particles comprised of the recombinant proteins are provided.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: March 30, 1999
    Assignee: Merck & Co. Inc.
    Inventors: Kathrin U. Jansen, James C. Cook, III, Hugh A. George, Kathryn J. Hofmann, Joseph G. Joyce, Ernest Dale Lehman, Henry Z. Markus, Mark Rosolowsky, Loren S. Schultz
  • DNA encoding human papillomavirus type 18
    Patent number: 5840306
    Abstract: The present invention is directed to DNA molecules encoding purified human papillomavirus type 18 and derivatives thereof.
    Type: Grant
    Filed: March 22, 1995
    Date of Patent: November 24, 1998
    Assignee: Merck & Co., Inc.
    Inventors: Kathryn J. Hofmann, Kathrin U. Jansen, Michael P. Neeper
  • Recombinant human papillomavirus type 18 vaccine
    Patent number: 5820870
    Abstract: The present invention is directed to vaccines for human papillomavirus type 18 and derivatives thereof.
    Type: Grant
    Filed: March 22, 1995
    Date of Patent: October 13, 1998
    Assignee: Merck & Co., Inc.
    Inventors: Joseph G. Joyce, Hugh A. George, Kathryn J. Hofman, Kathrin U. Jansen, Michael P. Neeper
  • Production of recombinant human papillomavirus type II protein utilizing papillomavirus 6/11 hybrid DNA
    Patent number: 5821087
    Abstract: The present invention is directed to a recombinant human papillomavirus type 11 L1 protein encoded by a synthetic DNA molecule and methods of making and using the protein.
    Type: Grant
    Filed: September 11, 1996
    Date of Patent: October 13, 1998
    Assignee: Merck & Co., Inc.
    Inventors: Robert Lowe, Joseph G. Joyce, Hugh A. George, Kathryn J. Hofmann, Kathrin U. Jansen, E. Dale Lehman, Michael P. Neeper